statistiche ricercatore

SQUIZZATO, ALESSANDRO

Distribuzione geografica

Continente	#
NA - Nord America	20.631
EU - Europa	11.868
AS - Asia	2.657
Continente sconosciuto - Info sul continente non disponibili	31
SA - Sud America	18
AF - Africa	11
OC - Oceania	10
Totale	35.226

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	20.609
IT - Italia	5.671
UA - Ucraina	1.934
TR - Turchia	1.373
RU - Federazione Russa	1.042
SE - Svezia	960
DE - Germania	686
VN - Vietnam	616
IE - Irlanda	568
CN - Cina	545
FI - Finlandia	410
GB - Regno Unito	322
FR - Francia	141
IN - India	51
EU - Europa	31
JP - Giappone	29
CZ - Repubblica Ceca	28
BE - Belgio	25
CA - Canada	21
NL - Olanda	16
PT - Portogallo	13
RO - Romania	10
SG - Singapore	10
BR - Brasile	8
AU - Australia	7
CL - Cile	6
ES - Italia	6
AT - Austria	5
CH - Svizzera	5
EG - Egitto	5
KR - Corea	5
HK - Hong Kong	4
HU - Ungheria	4
MK - Macedonia	4
AE - Emirati Arabi Uniti	3
IL - Israele	3
MY - Malesia	3
NZ - Nuova Zelanda	3
PE - Perù	3
PL - Polonia	3
RS - Serbia	3
AL - Albania	2
DK - Danimarca	2
KZ - Kazakistan	2
MA - Marocco	2
MD - Moldavia	2
NG - Nigeria	2
NO - Norvegia	2
PH - Filippine	2
TW - Taiwan	2
AR - Argentina	1
AZ - Azerbaigian	1
BD - Bangladesh	1
BG - Bulgaria	1
GR - Grecia	1
KE - Kenya	1
KH - Cambogia	1
LK - Sri Lanka	1
LT - Lituania	1
MN - Mongolia	1
NP - Nepal	1
PK - Pakistan	1
PR - Porto Rico	1
SI - Slovenia	1
TH - Thailandia	1
TN - Tunisia	1
UZ - Uzbekistan	1
Totale	35.226

Salva come PNG Salva come JPEG

Città	#
Milan	4.066
Fairfield	3.299
Woodbridge	2.390
Houston	1.743
Ashburn	1.608
Jacksonville	1.530
Chandler	1.396
Seattle	1.326
Ann Arbor	1.253
Wilmington	1.198
Cambridge	1.115
Moscow	1.006
Izmir	657
Princeton	594
Dublin	567
Dearborn	515
Nyköping	459
Dong Ket	300
Rome	292
Como	170
San Diego	168
San Mateo	154
Ogden	110
Beijing	98
Hefei	69
Kocaeli	67
New York	67
Düsseldorf	58
London	57
Washington	54
Kunming	52
Redmond	47
Boardman	45
Nanjing	45
Verona	36
Norwalk	34
Dallas	33
Los Angeles	28
Tokyo	28
Brno	27
Jinan	27
Nanchang	27
Frankfurt am Main	26
Berlin	22
Redwood City	22
Guangzhou	21
Brussels	20
Helsinki	20
Falls Church	18
Munich	18
Prescot	18
Kilburn	17
Ponte Lambro	17
Chicago	14
Shenyang	14
Hounslow	13
Zhengzhou	13
Besana In Brianza	12
Genoa	12
Pune	12
Varese	12
Chiswick	11
Toronto	11
Changsha	10
Fuzhou	10
Chongqing	9
Hangzhou	8
Lappeenranta	8
Philadelphia	8
Ralingen	8
Chengdu	7
Hebei	7
New Bedfont	7
Ningbo	7
Phoenix	7
Quzhou	7
Shaoxing	7
Southwark	7
Wuhan	7
Busto Arsizio	6
Jinhua	6
São Paulo	6
Trieste	6
West Jordan	6
Xian	6
Acton	5
Bergamo	5
Casnate Con Bernate	5
Hanoi	5
Indiana	5
Monza	5
Stockholm	5
Wandsworth	5
Amsterdam	4
Auburn Hills	4
Bollate	4
Budapest	4
Cantu	4
Eppelborn	4
Esslingen am Neckar	4
Totale	27.386

Salva come PNG Salva come JPEG

Nome	#
10 years of stagnant clinical research in the Italian academic context	1.116
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study	252
Multimorbidity and polypharmacy in the elderly: lessons from REPOSI.	227
Risk of recurrence of unusual site venous thromboembolism	211
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both	205
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study	203
Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: A longitudinal study during atorvastatin treatment	200
Oral anticoagulant therapy in patients with mechanical heart valve and intracranial haemorrhage. A systematic review	196
PCSK9 inhibitors for treating dyslipidemia in patients at different cardiovascular risk: a systematic review and a meta-analysis	192
Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari Syndrome	192
Abdominal obesity and the risk of recurrent deep vein thrombosis	190
Heart failure and chronic kidney disease in a registry of internal medicine wards	189
Optimal treatment duration of venous thrombosis	188
Impact of neutrophils to lymphocytes ratio on major clinical outcomes in patients with acute coronary syndromes: A systematic review and meta-analysis of the literature	186
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients	186
Patient selection for thromboprophylaxis in medical inpatients	184
Gender-differences in disease distribution and outcome in hospitalized elderly: data from the REPOSI study.	184
Diagnostic accuracy of lung ultrasound for pulmonary embolism: a systematic review and meta-analysis.	183
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia	182
Association between ABCG2 and ABCB1 genes and warfarin stability: a case-control study	181
Diagnosis of overt and non-overt disseminated intravascular coagulation: A survey among experts and a call for action from the ISTH	181
Subclinical hypothyroidism and deep venous thrombosis. A pilot cross-sectional study	179
Vitamin D Deficiency has a Negative Impact on Cetuximab-Mediated Cellular Cytotoxicity against Human Colon Carcinoma Cells	179
Diagnosis and management of venous thromboembolism: Results of a survey on current clinical practice	178
Prognostic stratification of chronic heart failure in elderly population: are cardiopulmonary tests and BNP really valuable?	176
Imatinib discontinuation in chronic myeloid leukaemia patients with undetectable BCR-ABL transcript level: A systematic review and a meta-analysis	176
Unsuspected pulmonary embolism in cancer patients: a narrative review with pooled data	174
Effect of thromboprophylaxis with anticoagulant drugs on the incidence of arterial thrombotic events in medical inpatients: a systematic review	174
Acquired von Willebrand syndrome in patients with overt hypothyroidism: a prospective cohort study	173
Prevention of venous thromboembolism and persistent vegetative state: a medical and an ethical issue	172
Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature	172
Prevalence and Clinical History of Incidental, Asymptomatic Pulmonary Embolism: A Meta-Analysis	172
Prevalence and Risk Factors Associated with Use of QT-Prolonging Drugs in Hospitalized Older People	171
Cangrelor for the treatment of arterial thrombosis: pharmacokinetics/pharmacodynamics and clinical data	170
Treating patients with cancer and acute venous thromboembolism	169
Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation	169
Differential diagnosis of pulmonary embolism in outpatients with non-specific cardiopulmonary symptoms.	168
Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism	168
A case report and literature review of portal vein thrombosis associated with Cytomegalovirus infection in immunocompetent patients	165
Diagnostic accuracy of magnetic resonance imaging in patients with suspected pulmonary embolism: A bivariate meta-analysis	164
Post-operative arterial thrombosis with non-vitamin K antagonist oral anticoagulants after total hip or knee arthroplasty	163
Thrombosis Associated with Viral Hepatitis	162
Factors associated with anticoagulation prescription in elderly patients with atrial fibrillation	162
Balloon Pulmonary Angioplasty in Patients With Chronic Thromboembolic Pulmonary Hypertension - A Systematic Review and Meta-Analysis -	162
Imaging for the diagnosis of pulmonary embolism in very obese patients; a survey among internists and radiologists in Italy and the Netherlands	161
Pulmonary embolism prognostic factors and length of hospital stay: A cohort study	161
Applying EBM in clinical practice	160
Non-vitamin K oral anticoagulants in patients with pulmonary embolism: a systematic review and meta-analysis of the literature	160
Statins and secondary prevention of ischemic and hemorrhagic stroke	159
Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia	158
Pulmonary Embolism Severity Index Accurately Predicts Long-Term Mortality Rate In Patients Hospitalized For Acute Pulmonary Embolism	158
Evaluation of the prevalence of severe hyperhomocysteinemia in adult patients with thrombosis who underwent screening for thrombophilia	158
Gender Difference in Efficacy and Safety of Nonvitamin K Antagonist Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation or Venous Thromboembolism: A Systematic Review and a Meta-Analysis of the Literature	158
Time trends and case fatality rate of in-hospital treated pulmonary embolism during 11 years of observation in Northwestern Italy	158
Predictors of residual venous obstruction after deep vein thrombosis of the lower limbs: a prospective cohort study	157
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study	156
Hypothyroidism and acquired von Willebrand's syndrome: a systematic review	155
Presence of residual thromboemboli at least six months after a first episode of symptomatic pulmonary embolism: do perfusion scintigraphy and angio-computed tomography agree?	154
sRAGE and early signs of cardiac target organ damage in mild hypertensives	152
How I treat splanchnic vein thrombosis	150
The role of thrombolytic therapy in pulmonary embolism	150
Statins for acute ischemic stroke	150
ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations—comment	150
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation	149
In vitro effects of Apixaban on 5 different cancer cell lines	149
Antithrombotic and fibrinolytic drugs for retinal vein occlusion: a systematic review and a call for action.	148
The 8th American college of chest physicians guidelines - A perspective on venous thromboembolism guidelines	148
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids	148
Antithrombotic therapy and cancer.	147
The initial phase of oral anticoagulation with warfarin in outpatients with deep venous thrombosis.	147
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity	147
Oral Anticoagulation Therapy in Heart Failure Patients in Sinus Rhythm: A Systematic Review and Meta-Analysis	147
The effect of thyroid autoantibodies on warfarin stability	147
Subclinical hypothyroidism and deep venous thrombosis. A pilot cross-sectional study	146
Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia	146
Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature: a reply to a rebuttal	145
Association between the metabolic syndrome, its individual components, and unprovoked venous thromboembolism: Results of a patient-level meta-analysis	144
Imatinib (IM) discontinuation in chronic myeloid leukemia (CML): A pharmacogenetic score for patients with durable complete molecular response (CMR)	144
Thyroid dysfunction and effects on coagulation and fibrinolysis - a systematic review	143
Effects of mineralocorticoid receptor antagonists on the risk of thrombosis, bleeding and mortality: A systematic review and meta-analysis of randomized controlled trials	143
The stigma of low opioid prescription in the hospitalized multimorbid elderly in Italy	143
Atypical case of Acute Coronary Syndrome due to Coronary-Pulmonary Steal Syndrome secondary to Pulmonary Embolism.	142
A systematic review on the effect of aspirin in the prevention of post-operative arterial thrombosis in patients undergoing total hip and total knee arthroplasty	141
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study	140
JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis.	139
Certoparin for the treatment and prevention of thrombosis: pharmacological profile and results from clinical studies	138
Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events	138
Decreased active von Willebrand factor level owing to shear stress in aortic stenosis patients.	136
A new era for venous thromboembolism prevention in medical inpatients	136
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register	135
The influence of pituitary, adrenal, and parathyroid hormones on hemostasis and thrombosis.	135
Short-term prognosis of intracranial haemorrhage in patients on oral anticoagulant or antiplatelet drugs	135
The role of the metabolic syndrome in patients with provoked venous thromboembolic events	135
Statins, fibrates, and venous thromboembolism: a meta-analysis.	134
Evaluation of right ventricular function in patients with a previous episode of pulmonary embolism using tissue Doppler imaging.	134
Oral anticoagulant therapy in patients with mechanical heart valve and intracranial haemorrhage: A systematic review	134
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients	134
Application of a decision rule and a D-dimer assay in the diagnosis of pulmonary embolism	132
JAK2V617F mutation in patients with arterial thrombosis in the absence of overt myeloproliferative disease.	132
Aspirin plus clopidogrel vs aspirin alone for preventing cardiovascular events among patients at high risk for cardiovascular events	132
Totale	17.124

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	124.120
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	124.120

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2019/2020	6.869	0	297	455	1.402	452	774	1.041	853	578	458	121	438
2020/2021	6.016	115	570	559	591	397	626	297	498	731	476	480	676
2021/2022	3.237	383	490	178	106	170	222	146	166	165	532	285	394
2022/2023	3.881	412	208	309	405	279	833	17	493	571	127	112	115
2023/2024	7.600	1.065	1.035	1.054	1.222	1.257	597	428	437	172	211	43	79
2024/2025	90	47	43	0	0	0	0	0	0	0	0	0	0
Totale													35.593